Clinical researchers at the Erasmus University Medical Centre in Rotterdam, the Netherlands, will use Roche and Caliper Life Sciences' combined automated target enrichment platform for a new 3,000-sample exome sequencing study, the partners said this week.

Under the agreement, the Genetic Laboratory of the Department of Internal Medicine at EUMC will use the combined Roche-Caliper offering as part of a new phase of the Rotterdam Study, a large, prospective human epidemiological cohort to characterize and analyze age-related disorders and their risk factors.